Users Stopping Anti-Obesity Injections Regain Pounds Far More Rapidly Compared to Those on Conventional Diets

A recent study reveals that patients who stop using blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who end conventional lifestyle plans.

Published data in a leading medical journal shows that while overweight people can lose a large proportion of their total mass while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit.

"Individuals purchasing such treatments need to be aware of the potential of rapid rebound weight gain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

This pace of regain means a reversion to original mass in about one and a half years.

Analyzing Approaches

The study, which reviewed dozens of trials involving thousands of patients, contrasted the results of these new drugs with older methods.

Researchers emphasize that individuals who shed pounds through diet and exercise typically see a slower weight regain—approximately 0.1 kg a month—after stopping.

Explaining the Quick Rebound

Experts suggest the way of the jabs accounts for the accelerated weight return.

These medications imitate a body's own chemical called GLP-1, which helps regulate appetite.

"Long-term administration of the hormone concentrations far above than normal might result in the system to produce less of its own natural hormone, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication means appetite is uncontrolled, making binge eating much more probable."

A Lifelong Issue?

Medical guidelines recommend the jabs for people with obesity-related health risks, alongside recommended lifestyle changes.

Many experts say that, considering the high risk of weight regain, the treatment is often long-term.

This opinion is reinforced by pharmaceutical companies, who say that the findings "highlight the long-term nature of obesity," similar to managing diseases like diabetes.

Patient Testimonies

Users who have come off the jabs explain a powerful return of cravings.

"I experienced something activating and you're instantly starving," recalled an individual.

This challenge is exacerbated if patients have not established permanent dietary or behavioural changes during treatment.

Widespread Interest

Recent estimates show that a significant number of people in the UK have used these injections in the last 12 months, with interest continuing to grow.

• Use is higher among women than males.
• The 40s and 50s age group shows the greatest level of interest.
• Many obtain the drugs through private prescriptions rather than the NHS.

Ultimately, clinicians caution that while GLP-1 drugs are potent agents for shedding pounds, they are not a standalone fix and maintained weight loss relies on combined behavioural changes.